Establishment of a Therapeutic Goods Evaluation Panel

The Therapeutic Goods Administration (TGA), a part of the Department of Health, is seeking to establish a Therapeutic Goods Evaluation Panel to provide medical and scientific evaluation services. The Therapeutic Goods Evaluation Panel is expected to deliver evaluation services for technical streams as follows: 1. Clinical medicines and clinical technologies 2. Nonclinical sciences (pharmacology/toxicology) 3. Quality of pharmaceutical therapeutic goods (synthetic pharmaceuticals, biological sciences) Evaluation services are in the form of a written evaluation report comprising review and critical evaluation of quality, safety and efficacy data on medicines, as submitted by pharmaceutical companies. The evaluation reports are prepared in a format prescribed by the TGA, and following procedures determined by the TGA.

Comments are closed.